Short Report
Hero Background

Cut through the noise.
Trade on the signal.

A weekly synthesis of institutional-grade financial reports and market mechanics.

No spam. Unsubscribe anytime.

All Reports

Filters

Companies

Tickers

Authors

Latest Reports

Author: Two Natural Capital Ticker: SRPT

Sarepta Therapeutics: From Exon-Skipping to Gene Therapy

Sarepta Therapeutics' ELEVIDYS gene therapy for Duchenne muscular dystrophy faces critical challenges: controversial FDA approval, $3.2M price tag, limited efficacy, and potential competitive threats from emerging genetic treatments

Dec 12, 2024 3 min read
Author: DF Research Ticker: BIP

Brookfield Infrastructure Partners: The Quiet Collapse

Brookfield Infrastructure Partners (BIP) faces critical cash flow crisis with 70% downside risk, unsustainable distributions, and potential financial collapse amid asset underperformance, management fees, and questionable financial engineering tactics

Dec 11, 2024 4 min read
Author: Viceroy Research Ticker: GL

Globe Life - Legal Hold Notice

Globe Life faces DOJ investigation allegations of evidence destruction at American Income Life, with Viceroy Research exposing potential document tampering, agency closures, and critical legal hold notice violations threatening federal probe integrity

Dec 9, 2024 3 min read
Author: Viceroy Research Ticker: GL

Globe Life – Adios, Arias

Viceroy Research exposes Globe Life's American Income Life agency network collapse, revealing systematic closures, falsified virtual transition claims, and potential operational fraud through comprehensive investigative analysis

Dec 5, 2024 3 min read
Author: Viceroy Research Company: Corning

Globe Life – Closing Time

Globe Life stock faces critical operational crisis: 40% of AIL sales agencies closing, massive revenue collapse, potential regulatory risks, and undisclosed material changes threatening company's financial stability and investor confidence

Dec 4, 2024 3 min read
Author: The Captain's Log Ticker: ZETA

Zeta Global (NYSE: ZETA) Has a Deeper Relationship with Kubient Fraudster Paul Roberts Than Reported

Zeta Global NYSE ZETA exposed: SEC investigation reveals deep ties to Kubient fraud, Paul Roberts connections, and questionable data harvesting practices in AI marketing tech sector

Dec 4, 2024 3 min read
Author: The Captain's Log Ticker: ZETA

Zeta Global (NYSE: ZETA) CEO David Steinberg is Now Lying on CNBC About Zeta Global Consent Farms

Zeta Global exposed: NYSE ZETA's controversial data harvesting practices revealed, AI marketing deception uncovered. CEO David Steinberg's consent farm operations raise serious investor and regulatory concerns about unethical data collection strategies

Nov 29, 2024 3 min read
Author: Fuzzy Panda Research Ticker: ASPI

ASP Isotopes (ASPI): Failed Tech + Paid Stock Promotion + “Microcap Fraudsters” (Honig & Stetson) = Nuclear Meltdown

ASP Isotopes (ASPI) exposed: Obsolete uranium enrichment tech, SEC-banned promoters, fraudulent stock scheme with zero NRC licensing and misleading investor claims revealed by Fuzzy Panda Research investigation

Nov 26, 2024 4 min read
Author: The Captain's Log Ticker: ZETA

Examining Zeta Global (NYSE: ZETA) Management Lies on Their Recent Media Tour

Zeta Global (ZETA) accused of consent farms, data harvesting fraud, and misleading investors through creative revenue reporting, with potential securities violations exposed by investigative report on NYSE-listed marketing tech company

Nov 22, 2024 4 min read
Author: White Diamond Research Ticker: ILLR

The Agba Group/Triller Merger Is A Scheme to Temporarily Boost Agba’s Stock Price – Both Companies Are Practically Worthless/Bankrupt And It Likely Won’t Get Approved By Regulators Anyways

White Diamond Research exposes AGBA-Triller merger as a stock manipulation scheme, revealing financial fraud, regulatory risks, and zero business synergy in a damning analysis of two practically bankrupt companies seeking artificial stock inflation

Nov 7, 2024 4 min read
Author: Fuzzy Panda Research Ticker: LRN

Stride Inc (LRN) – The Last Covid Over Earner – Hiding That Est >25% of EBITDA Came from Covid Funds

Stride Inc. faces critical financial challenges as $330M COVID relief funds expire, with allegations of ghost students, undisclosed school losses, and questionable billing practices threatening its K-12 online education business model and stock performance

Oct 16, 2024 3 min read
Author: Capybara Research Ticker: LASE

Laser Photonics Corp: The Culmination of 25 Years of Fraud

Explosive Capybara Research report reveals Laser Photonics (LASE) as 25-year fraud machine led by serial fraudster Dmitri Nikitin, exposing systematic financial misconduct, stock manipulation, and deceptive business practices in tech startup fraud investigation

Oct 1, 2024 4 min read

The Signal. No Noise.

Join 50,000+ investors receiving our weekly synthesis.